RxDoctor Payments Data

Walter Kay, DO

Family Medicine · Tarpon Springs, FLNPI 1013969575

Payments from drug & device makers

$826in general payments, 2019–2025

Across 43 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$288
  • AstraZeneca$180
  • Boehringer Ingelheim$119
  • Astellas Pharma US Inc$94
  • AbbVie$48
  • Amarin Pharma, Inc.$22
  • plus $75 from 5 others

What the payments were for

  • Food & beverage$75191%
  • Education$759%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$826 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$237,564
Medicare patients
337
Services billed
2,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban138$85,004
FarxigaDapagliflozin Propanediol97$58,355
MyrbetriqMirabegron63$30,443
XareltoRivaroxaban54$26,865
JardianceEmpagliflozin29$20,105
LinzessLinaclotide36$19,880
JanuviaSitagliptin Phosphate34$17,885
EntrestoSacubitril/Valsartan15$12,754
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,170
Breo ElliptaFluticasone/Vilanterol24$9,622
Advair HfaFluticasone Propion/Salmeterol25$7,807
Combivent RespimatIpratropium/Albuterol Sulfate12$7,759
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,622
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$6,406
SymbicortBudesonide/Formoterol Fumarate22$5,509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta$180$76,931144 claims
Astellas Pharma US IncMyrbetriq$94$30,44363 claims
Boehringer IngelheimJardiance, Combivent Respimat$119$27,86441 claims
AbbVieLinzess$48$19,88036 claims
NovartisEntresto$288$12,75415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tarpon Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →